Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3635452013 | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 1479317011 | Tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3534602016 | Tablet (basic dose form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3865641000005115 | tablet | da | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Danish module (core metadata concept) |
| 4839601000005114 | tabletter | da | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Danish module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Is a | Type of drug preparation | false | Inferred relationship | Some | ||
| A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Is a | Oral dose form | false | Inferred relationship | Some | ||
| A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Is a | A dose form that displays properties of a solid. | true | Inferred relationship | Some | ||
| A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Has state of matter (attribute) | A state of matter where particles form a stable, definite shape that can only change by force (e.g. break, cut). | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| cefalexin 250 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| cefalexinhydrochlorid 500 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Cefixime 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Cefpodoxime (as cefpodoxime proxetil) 100 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Cefprozil 250 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Cefprozil 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| tetracyclin 250 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| kombinationspræparat med tetracyclin 300 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| doxycyclin 100 mg dispergibel tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| minocyclin 50 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| minocyclin 100 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| oxytetracyclindihydrat 250 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Neomycin sulfate 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Erythromycin 250 mg gastro-resistant oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Erythromycin 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely erythromycin (as erythromycin stearate) 250 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Erythromycin (as erythromycin stearate) 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Clarithromycin 250 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Clarithromycin 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| clarithromycin 500 mg tablet med modificeret udløsning | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| azithromycin 500 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Spiramycin 250 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| colistinsulfat 1,5 million enheder tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Sodium fusidate 250 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely sulfamethoxazole 400 milligram and trimethoprim 80 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| co-trimoxazol 80 mg/400 mg dispergibel tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Sulfamethoxazole 800 mg and trimethoprim 160 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| co-trimoxazol 160 mg/800 mg dispergibel tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| co-trimoxazol 40 mg/80 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely sulfalene 2 gram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Sulfadiazine 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Sulfaguanidine 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Trimethoprim 100 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Trimethoprim 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Ethambutol hydrochloride 100 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Ethambutol hydrochloride 400 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Isoniazid 50 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Isoniazid 100 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Pyrazinamide 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely isoniazid 100 milligram and rifampicin 150 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely isoniazid 150 milligram and rifampicin 300 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Dapsone 50 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Dapsone 100 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Metronidazole 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Metronidazole 400 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Metronidazole 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Tinidazole 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Nitrofurantoin 50 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Nitrofurantoin 100 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| hexaminhippurat tablet 1 g | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Nalidixic acid 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| ciprofloxacin 100 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| ciprofloxacin 750 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| ciprofloxacin 500 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| ciprofloxacin 250 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Ofloxacin 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Ofloxacin 400 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Norfloxacin 400 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Levofloxacin 250 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Levofloxacin 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| amphotericin 100 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Flucytosine 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Griseofulvin 125 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Griseofulvin 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Ketoconazole 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Nystatin 500000 unit oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Terbinafine (as terbinafine hydrochloride) 250 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Aciclovir 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Aciclovir 400 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| aciclovir 800 mg dispergibel tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| aciclovir 200 mg dispergibel tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| aciclovir 400 mg dispergibel tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Aciclovir 800 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Inosine pranobex 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Famciclovir 250 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Famciclovir 125 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Famciclovir 750 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Famciclovir 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Didanosine 150 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Didanosine 25 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Didanosine 100 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Didanosine 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Zalcitabine 750 microgram oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely zalcitabine 375 microgram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely valaciclovir (as valaciclovir hydrochloride) 500 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Lamivudine 150 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Lamivudine 100 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Lamivudine 150 mg and zidovudine 300 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Nevirapine 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Nelfinavir (as nelfinavir mesilate) 250 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| abacavir 300 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Chloroquine phosphate 250 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| primaquin 7,5 mg tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Proguanil hydrochloride 100 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Product containing precisely dapsone 100 milligram and pyrimethamine 12.5 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Pyrimethamine 25 mg and sulfadoxine 500 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Pyrimethamine 25 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Quinine bisulfate 300 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Quinine dihydrochloride 300 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Quinine hydrochloride 300 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some | |
| Quinine sulfate 200 mg oral tablet | Has manufactured dose form | False | A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. | Inferred relationship | Some |
Start Previous Page 9 of 28 Next End
This concept is not in any reference sets
FHIR